In order to further improve therapy quality, increase convenience and drive patient engagement to manage their health, the two firms intend to advance chronic care management using connected therapy.
As part of the deal, Qualcomm Life‘s 2net platform will be used to securely capture data from a patient’s medical devices, starting with anticoagulation meters, and transmit it to Roche’s cloud-based back-end services.
Roche Professional Diagnostics point of care senior vice-president Jeremy Moss said: "By combining Qualcomm Life’s leadership in powering connected health solutions with our point-of-care expertise, we are taking an important step forward to realise our connected care strategy; ultimately enabling physicians to improve the overall quality of life for patients."
According to the company, the 2net platform is a secure wireless solution that offers a simple and efficient way to exchange relevant health information between chronic disease patients and their care team or clinic to enable reduced therapy complications and total cost of care.
Qualcomm Life senior vice-president Rick Valencia said: "We are thrilled to be working with a global industry leader in diagnostics and excited by the positive impact our collaboration with Roche can have on patient empowerment at the point-of-care."
The company said that connected chronic care management and remote management solutions can improve patient care, allowing health care providers to asynchronously communicate with patients in a high-tech, high-touch model, reducing risk of errors in result reporting.